Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-06-03 @ 3:12 AM
Study NCT ID:
NCT07340320
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-01-14
First Post:
2026-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Sponsor:
Corxel Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Type II Diabetes Mellitus | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Type 2 Diabetes Mellitus | View |
| None | HbA1C | View |
| None | Percentage change in HbA1C | View |
| None | Change in Fasting Plasma Glucose | View |
| None | Change in body weight | View |
| None | Body weight loss | View |
| None | Hypoglycemics episodes | View |
| None | Hypoglycemia | View |
| None | Continuous Glucose Monitoring | View |
| None | Blood glucose | View |
| None | Health Survey Short Form-36 | View |
| None | Diabetes treatment satisfaction questionnaire | View |
| None | Columbia-suicide severity rating scale | View |